Literature DB >> 3585318

Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile.

A Nordberg, P Nyberg, R Adolfsson, B Winblad.   

Abstract

The topographical distribution of the choline acetyltransferase (ChAT) activity and the number of muscarinic binding sites was studied in the anterio-posterior direction of the caudate nucleus, hippocampus, globus pallidus and putamen of four subjects with senile dementia of Alzheimer type (AD/SDAT) and in the same regions in six controls. Intranuclear gradients were observed both for ChAT and muscarinic receptors. The data obtained were compared with data on noradrenaline (NA) concentration. With longer duration of the disease a decrease was found in the noradrenergic and cholinergic systems. One patient died acutely after a rather short duration of the disease. In this patient no change in ChAT activity was found while the NA concentration was decreased in all brain regions. An upregulation of the number of muscarinic receptors was observed in the caudate nucleus and putamen of all cases, except for the case with the shortest duration of the disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3585318     DOI: 10.1007/bf01244094

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  35 in total

1.  Transmitter deficits in Alzheimer's disease.

Authors:  J Hardy; R Adolfsson; I Alafuzoff; G Bucht; J Marcusson; P Nyberg; E Perdahl; P Wester; B Winblad
Journal:  Neurochem Int       Date:  1985       Impact factor: 3.921

2.  A rapid radiochemical method for the determination of choline acetyltransferase.

Authors:  F Fonnum
Journal:  J Neurochem       Date:  1975-02       Impact factor: 5.372

3.  Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.

Authors:  R C Pearson; M V Sofroniew; A C Cuello; T P Powell; F Eckenstein; M M Esiri; G K Wilcock
Journal:  Brain Res       Date:  1983-12-19       Impact factor: 3.252

4.  Cholinergic receptors in human hippocampus-- regional distribution and variance with age.

Authors:  A Nordberg; B Winblad
Journal:  Life Sci       Date:  1981-11-09       Impact factor: 5.037

5.  Correlation between senile plaque and neurofibrillary tangle counts in cerebral cortex and neuronal counts in cortex and subcortical structures in Alzheimer's disease.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  Neurosci Lett       Date:  1985-05-01       Impact factor: 3.046

6.  Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease.

Authors:  R H Perry; J M Candy; E K Perry; D Irving; G Blessed; A F Fairbairn; B E Tomlinson
Journal:  Neurosci Lett       Date:  1982-12-13       Impact factor: 3.046

7.  Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia.

Authors:  Y Ichimiya; H Arai; K Kosaka; R Iizuka
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

8.  Topographic distribution of choline acetyltransferase activity and muscarinic and nicotinic receptors in Parkinson brains.

Authors:  A Nordberg; P Nyberg; B Windblad
Journal:  Neurochem Pathol       Date:  1985

9.  Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains.

Authors:  A Nordberg; B Winblad
Journal:  Neurosci Lett       Date:  1986-12-03       Impact factor: 3.046

10.  Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer's type: possible role in cell loss.

Authors:  C B Saper; D C German; C L White
Journal:  Neurology       Date:  1985-08       Impact factor: 9.910

View more
  3 in total

1.  Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography.

Authors:  J J Claus; E A Dubois; J Booij; J Habraken; J C de Munck; M van Herk; B Verbeeten; E A van Royen
Journal:  Eur J Nucl Med       Date:  1997-06

2.  Differential cholinergic regulation in Alzheimer's patients compared to controls following chronic blockade with scopolamine: a SPECT study.

Authors:  T Sunderland; G Esposito; S E Molchan; R Coppola; D W Jones; J Gorey; J T Little; M Bahro; D R Weinberger
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

3.  Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease.

Authors:  D J Wyper; D Brown; J Patterson; J Owens; R Hunter; E Teasdale; J McCulloch
Journal:  Eur J Nucl Med       Date:  1993-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.